Skip to Content

MainStay PineStone International Eq C FCICX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 16.86  /  −0.47 %
  • Total Assets 525.6 Mil
  • Adj. Expense Ratio
    2.290%
  • Expense Ratio 2.290%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield
  • Turnover 12%

USD | NAV as of May 21, 2024 | 1-Day Return as of May 21, 2024, 9:49 PM GMT+0

Morningstar’s Analysis FCICX

Will FCICX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay PineStone International Eq C boasts strong Process and People Pillar ratings, but other weaknesses hold this strategy's Morningstar Medalist Rating at Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FCICX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd ADR

7.31 35.2 Mil
Technology

Novo Nordisk A/S Class B

7.26 34.9 Mil
Healthcare

London Stock Exchange Group PLC

4.90 23.6 Mil
Financial Services

Lvmh Moet Hennessy Louis Vuitton SE

4.69 22.6 Mil
Consumer Cyclical

Nestle SA

4.57 22.0 Mil
Consumer Defensive

ASML Holding NV

4.36 21.0 Mil
Technology

Air Liquide SA

4.19 20.2 Mil
Basic Materials

InterContinental Hotels Group PLC

4.12 19.8 Mil
Consumer Cyclical

Essilorluxottica

3.94 18.9 Mil
Healthcare

Compagnie Financiere Richemont SA Class A

3.45 16.6 Mil
Consumer Cyclical